# Development and Prevention of Severe Heart Disease in Systemic Sclerosis

> **NCT01829126** · — · UNKNOWN · sponsor: **Gabriele Valentini** · enrollment: 765 (estimated)

## Conditions studied

- Systemic Sclerosis
- Cardiac Diseases
- Heart Block
- Cardiac Arrhythmia
- Congestive Heart Failure

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01829126
- **Lead sponsor:** Gabriele Valentini
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-04
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 765 (ESTIMATED)
- **Last updated:** 2013-11-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01829126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01829126, "Development and Prevention of Severe Heart Disease in Systemic Sclerosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01829126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*